Cite
HARVARD Citation
Chari, A. et al. (2018). Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma. Cancer. 124 (22), pp. 4342-4349. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chari, A. et al. (2018). Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma. Cancer. 124 (22), pp. 4342-4349. [Online].